Growth Metrics

Merck (MRK) EBIT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -262.69%
Dec 31, 2025 -173.74%
Sep 30, 2025 100.42%
Jun 30, 2025 -41.95%
Mar 31, 2025 626.32%
Dec 31, 2024 3,320.00%
Sep 30, 2024 -99.56%
Jun 30, 2024 6.15%
Mar 31, 2024 135.75%
Dec 31, 2023 -539.38%
Sep 30, 2023 114.49%
Jun 30, 2023 -3,290.94%
Mar 31, 2023 25.00%
Dec 31, 2022 -4.84%
Sep 30, 2022 -229.52%
Jun 30, 2022 152.22%
Mar 31, 2022 -1,582.86%
Dec 31, 2021 -98.07%
Sep 30, 2021 230.93%
Jun 30, 2021 -554.25%
Mar 31, 2021 97.20%
Dec 31, 2020 -2,367.10%
Sep 30, 2020 -5,016.67%
Jun 30, 2020 -101.14%
Mar 31, 2020 117.11%
Dec 31, 2019 -87.16%
Sep 30, 2019 -1,057.04%
Jun 30, 2019 -1,046.67%
Mar 31, 2019 102.19%
Dec 31, 2018 28.20%
Sep 30, 2018 28.32%
Jun 30, 2018 27.62%
Mar 31, 2018 -17.81%
Dec 31, 2017 49.76%
Sep 30, 2017 -358.94%
Jun 30, 2017 35.28%
Mar 31, 2017 78.33%
Dec 31, 2016 -824.71%
Sep 30, 2016 74.83%
Jun 30, 2016 -6.47%
Mar 31, 2016 35.79%
Dec 31, 2015 -122.43%
Sep 30, 2015 53.72%
Jun 30, 2015 -34.69%
Mar 31, 2015 -127.14%
Dec 31, 2014 394.99%
Sep 30, 2014 8.96%
Jun 30, 2014 -65.67%
Mar 31, 2014 46.42%
Dec 31, 2013 -31.14%
Sep 30, 2013 15.14%
Jun 30, 2013 -26.15%
Mar 31, 2013 14.76%
Dec 31, 2012 -47.26%
Sep 30, 2012 -34.01%
Jun 30, 2012 6.41%
Mar 31, 2012 41.04%
Dec 31, 2011 -29.75%
Sep 30, 2011 23.43%
Jun 30, 2011 -12.10%
Mar 31, 2011 54.68%
Dec 31, 2010 -39.21%
Sep 30, 2010 -11.64%
Jun 30, 2010 -612.87%
Mar 31, 2010 137.41%
Dec 31, 2009 -207.93%
Sep 30, 2009 15.44%
Jun 30, 2009 22.46%